Seegene, Inc. (096530.KQ)
KRW 23550.0
(-1.26%)
KRW 23550.0
(-1.26%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 137.63 Billion KRW | -13.0% |
| 2022 | 158.19 Billion KRW | -26.24% |
| 2021 | 214.46 Billion KRW | 54.18% |
| 2020 | 139.1 Billion KRW | 644.97% |
| 2019 | 18.67 Billion KRW | -20.82% |
| 2018 | 23.58 Billion KRW | 16.03% |
| 2017 | 20.32 Billion KRW | 49.52% |
| 2016 | 13.59 Billion KRW | -8.01% |
| 2015 | 14.77 Billion KRW | 20.91% |
| 2014 | 12.21 Billion KRW | 38.19% |
| 2013 | 8.84 Billion KRW | 87.05% |
| 2012 | 4.72 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 123.45 Billion KRW | -4.53% |
| 2024 Q1 | 129.31 Billion KRW | -6.05% |
| 2023 Q2 | 149.86 Billion KRW | -6.57% |
| 2023 Q4 | 137.63 Billion KRW | 2.14% |
| 2023 FY | 137.63 Billion KRW | -13.0% |
| 2023 Q1 | 160.4 Billion KRW | 1.39% |
| 2023 Q3 | 134.74 Billion KRW | -10.09% |
| 2022 Q4 | 158.19 Billion KRW | 0.33% |
| 2022 Q3 | 157.67 Billion KRW | -30.45% |
| 2022 Q2 | 226.71 Billion KRW | 25.16% |
| 2022 Q1 | 181.14 Billion KRW | -15.54% |
| 2022 FY | 158.19 Billion KRW | -26.24% |
| 2021 Q1 | 221.86 Billion KRW | 59.5% |
| 2021 Q4 | 214.46 Billion KRW | -14.44% |
| 2021 Q3 | 250.65 Billion KRW | -10.69% |
| 2021 FY | 214.46 Billion KRW | 54.18% |
| 2021 Q2 | 280.64 Billion KRW | 26.49% |
| 2020 Q3 | 94.27 Billion KRW | 48.92% |
| 2020 FY | 139.1 Billion KRW | 644.97% |
| 2020 Q1 | 22.16 Billion KRW | 18.73% |
| 2020 Q2 | 63.3 Billion KRW | 185.56% |
| 2020 Q4 | 139.1 Billion KRW | 47.55% |
| 2019 Q1 | 22.32 Billion KRW | -5.34% |
| 2019 FY | 18.67 Billion KRW | -20.82% |
| 2019 Q3 | 24.31 Billion KRW | -11.86% |
| 2019 Q2 | 27.58 Billion KRW | 23.58% |
| 2019 Q4 | 18.67 Billion KRW | -23.2% |
| 2018 Q3 | 22.42 Billion KRW | -3.94% |
| 2018 Q2 | 23.34 Billion KRW | 12.76% |
| 2018 Q1 | 20.7 Billion KRW | 1.87% |
| 2018 FY | 23.58 Billion KRW | 16.03% |
| 2018 Q4 | 23.58 Billion KRW | 5.16% |
| 2017 Q4 | 20.32 Billion KRW | 4.46% |
| 2017 Q2 | 17.33 Billion KRW | 25.27% |
| 2017 FY | 20.32 Billion KRW | 49.52% |
| 2017 Q1 | 13.83 Billion KRW | 1.82% |
| 2017 Q3 | 19.45 Billion KRW | 12.22% |
| 2016 FY | 13.59 Billion KRW | -8.01% |
| 2016 Q3 | 14.51 Billion KRW | -1.77% |
| 2016 Q1 | 14.53 Billion KRW | -1.59% |
| 2016 Q2 | 14.77 Billion KRW | 1.64% |
| 2016 Q4 | 13.59 Billion KRW | -6.37% |
| 2015 Q2 | 12.76 Billion KRW | 7.48% |
| 2015 FY | 14.77 Billion KRW | 20.91% |
| 2015 Q4 | 14.77 Billion KRW | 6.41% |
| 2015 Q3 | 13.88 Billion KRW | 8.77% |
| 2015 Q1 | 11.87 Billion KRW | -2.81% |
| 2014 Q4 | 12.21 Billion KRW | 65.33% |
| 2014 Q3 | 7.39 Billion KRW | -8.87% |
| 2014 Q2 | 8.1 Billion KRW | -16.62% |
| 2014 Q1 | 9.72 Billion KRW | 9.99% |
| 2014 FY | 12.21 Billion KRW | 38.19% |
| 2013 FY | 8.84 Billion KRW | 87.05% |
| 2013 Q3 | 6.21 Billion KRW | -11.31% |
| 2013 Q4 | 8.84 Billion KRW | 42.16% |
| 2013 Q1 | 5.37 Billion KRW | 13.73% |
| 2013 Q2 | 7.01 Billion KRW | 30.45% |
| 2012 FY | 4.72 Billion KRW | 0.0% |
| 2012 Q4 | 4.72 Billion KRW | 23.68% |
| 2012 Q3 | 3.82 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | 15.04 Billion KRW | -814.645% |
| InBody Co.,Ltd | 29.41 Billion KRW | -367.859% |
| Curexo Inc. | 31.77 Billion KRW | -333.207% |
| i-SENS, Inc. | 83.54 Billion KRW | -64.754% |
| Ray Co., Ltd. | 25.37 Billion KRW | -442.481% |
| Gencurix Inc. | 581.02 Million KRW | -23588.505% |
| Sugentech Inc. | 7.01 Billion KRW | -1860.725% |
| L&C Bio Co., Ltd | 46.28 Billion KRW | -197.347% |